{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Industrial Aid[C45678]" in comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
ANADA200587
(2016)
Source URL:
First approved in 2016
Source:
ANADA200587
Source URL:
Class:
POLYMER
Gleptoferron is a macromolecular complex of beta-ferric oxyhydroxide and dextran glucoheptonic acid that has been used for iron-deficiency anemia in veterinary medicine.
Status:
Possibly Marketed Outside US
Source:
NCT01416701: Phase 4 Interventional Withdrawn Chronic Obstructive Lung Disease
(2011)
Source URL:
First approved in 2008
Source:
Calcium Acetate 667 mg by Pharmin USA, LLC
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 2006
Source:
NDA205053
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 358H
(2009)
Source URL:
First approved in 2005
Source:
21 CFR 352
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
68 FR 32268 antigingivitis/plaque polydimethylsiloxane and poloxamer
Source URL:
First approved in 2004
Source:
ANDA076523
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA074806
(2004)
Source URL:
First approved in 2004
Source:
ANDA074806
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333E
(2012)
Source URL:
First approved in 2003
Source:
21 CFR 350
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2013)
Source URL:
First approved in 2003
Source:
ANDA065123
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M003
(1999)
Source URL:
First approved in 1999
Source:
M003
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Omnivex by Sterling Knight Pharmaceuticals LLC
(2018)
Source URL:
First approved in 1999
Source:
MagneBind 400 Rx by Nephro-Tech, Inc.
Source URL:
Class:
POLYMER
